Related Experiment Video
Updated: Nov 24, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Virus-mimetic systems for cancer diagnosis and therapy
Xihui Gao1, Junqiang Ding2, Qianqian Long1
1School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University, Shanghai, China.
Abstract:
Over past decades, various strategies have been developed to enhance the delivery efficiency of therapeutics and imaging agents to tumor tissues. However, the therapeutic outcome of tumors to date have not been significantly improved, which can be partly attributed to the weak targeting ability, fast elimination, and low stability of conventional delivery systems. Viruses are the most efficient agents for gene transfer, serving as a valuable source of inspiration for designing nanoparticle-based delivery systems. Based on the properties of viruses, including well-defined geometry, precise composition, easy modification, stable construction, and specific infection, researchers attempt to design biocompatible delivery vectors by mimicking virus assembly and using the vector system to selectively concentrate drugs or imaging probes in tumors with mitigated toxicity and improved efficacy. In this review, we introduce common viruses features and provide an overview of various virus-mimetic strategies for cancer therapy and diagnosis. The challenges faced by virus-mimetic systems are also discussed. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.
Insights
Virus-mimetic nanoparticles offer improved cancer therapy and diagnosis by mimicking viral structures for targeted drug delivery. These systems aim to overcome limitations of conventional methods, enhancing efficacy and reducing toxicity in oncologic disease treatment.
Area of Science:
- Nanomedicine
- Oncologic Disease
- Biotechnology
Background:
- Conventional drug delivery systems exhibit limitations in targeting tumors, leading to poor therapeutic outcomes.
- Viruses possess inherent properties like efficient gene transfer, stability, and specific targeting, making them ideal models for delivery systems.
- Existing nanoparticle-based delivery systems struggle with weak targeting, rapid elimination, and low stability.
Purpose of the Study:
- To review virus-mimetic strategies for enhancing therapeutic and diagnostic agent delivery to tumor tissues.
- To explore how mimicking viral assembly can create biocompatible vectors for targeted cancer treatment.
- To discuss the challenges and potential of virus-mimetic systems in nanomedicine for oncologic disease.
Main Methods:
- Review of scientific literature on virus features and their application in designing delivery systems.
- Analysis of strategies that mimic viral geometry, composition, and assembly for nanoparticle development.
- Discussion of methods for concentrating drugs or imaging agents in tumors using virus-mimetic vectors.
Main Results:
- Virus-mimetic strategies leverage viral properties to design stable, targetable, and modifiable delivery vectors.
- These systems show potential for improved drug/imaging agent accumulation in tumors.
- Mimicking viral assembly offers a pathway to enhanced efficacy and reduced toxicity in cancer therapy and diagnosis.
Conclusions:
- Virus-mimetic nanoparticle systems represent a promising approach to overcome limitations in current cancer nanomedicine.
- Further research into these strategies could significantly improve therapeutic outcomes and diagnostic capabilities for oncologic diseases.
- Addressing the challenges in virus-mimetic system development is crucial for their clinical translation.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Tumor Immunotherapy
Mechanisms of Retrovirus-induced Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

